Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 157, Issue 4, Pages 565-567Publisher
WILEY-BLACKWELL PUBLISHING, INC
DOI: 10.1111/j.1476-5381.2009.00193.x
Keywords
ascorbate deficiency; glyceryl trinitrate; nitric oxide; nitroglycerin; mitochondrial aldehyde dehydrogenase; tolerance
Categories
Funding
- British Heart Foundation [RG/05/003] Funding Source: Medline
Ask authors/readers for more resources
The organic nitrate drugs, such as glyceryl trinitrate (GTN; nitroglycerin), are clinically effective in angina because of their dilator profile in veins and arteries. The exact mechanism of intracellular delivery of nitric oxide (NO), or another NO-containing species, from these compounds is not understood. However, mitochondrial aldehyde dehydrogenase (mtALDH) has recently been identified as an organic nitrate bioactivation enzyme. Nitrate tolerance, the loss of effect of organic nitrates over time, is caused by reduced bioactivation and/or generation of NO-scavenging oxygen-free radicals. In a recent issue of the British Journal of Pharmacology, Wenzl et al. show that guinea-pigs, deficient in ascorbate, also have impaired responsiveness to GTN, but nitrate tolerance was not due to ascorbate deficiency that exhibited divergent changes in mtALDH activity. Thus, the complex function of mtALDH appears to be the key to activation of GTN, the active NO species formed and the induction of tolerance that can limit clinical effectiveness of organic nitrate drugs. British Journal of Pharmacology (2009) 157, 565-567; doi:10.1111/j.1476-5381.2009.00193.x This article is part of a themed section on Endothelium in Pharmacology. For a list of all articles in this section see the end of this paper, or visit: http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2009 The paper by Wenzl et al. is available fromhttp://www3.interscience.wiley.com/cgi-bin/fulltext/122221718/PDFSTART.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available